Efficacy and Safety of Antihyperglycemic Agents Added to Metformin Monotherapy in Patients with Type 2 Diabetes

被引：0
|
作者：
Mearns, Elizabeth S.
Sobieraj, Diana M.
White, C. Michael
Saulsberry, Whitney J.
Doleh, Yunes
Zaccaro, Eric
Coleman, Craig I.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2602-PO
引用
收藏
页码：A658 / A658
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
    F. J. Lavalle-González
    A. Januszewicz
    J. Davidson
    C. Tong
    R. Qiu
    W. Canovatchel
    G. Meininger
    [J]. Diabetologia, 2013, 56 : 2582 - 2592
  • [42] Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia
    Ji, Linong
    Liu, Yanmei
    Miao, Heng
    Xie, Yongli
    Yang, Ming
    Wang, Wei
    Mu, Yuting
    Yan, Ping
    Pan, Sharon
    Lauring, Brett
    Liu, Shu
    Huyck, Susan
    Qiu, Yanping
    Terra, Steven G.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1474 - 1482
  • [43] Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
    Lavalle-Gonzalez, F. J.
    Januszewicz, A.
    Davidson, J.
    Tong, C.
    Qiu, R.
    Canovatchel, W.
    Meininger, G.
    [J]. DIABETOLOGIA, 2013, 56 (12) : 2582 - 2592
  • [44] EFFICACY AND SAFETY OF ANAGLIPTIN COMPARED WITH SITAGLIPTIN AS AN ADD-ON FOR PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
    Jin, S. -M.
    Park, S. W.
    Yoon, K. -H.
    Lee, M. -K.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S135 - S136
  • [45] Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes inadequately controlled with metformin monotherapy: VERTIS-Asia
    Yang, M.
    Ji, L.
    Liu, Y.
    Miao, H.
    Xie, Y.
    Wang, W.
    Mu, Y.
    Yan, P.
    Pan, S.
    Lauring, B.
    Liu, S.
    Huyck, S.
    Wang, D.
    Terra, S. G.
    [J]. DIABETOLOGIA, 2018, 61 : S307 - S308
  • [46] Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes
    Vos, Rimke C.
    Rutten, Guy E. H. M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (15): : 1489 - 1490
  • [47] Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients
    Derosa, Giuseppe
    Maffioli, Pamela
    Salvadeo, Sibilla A. T.
    Ferrari, Ilaria
    Ragonesi, Pietro D.
    Querci, Fabrizio
    Franzetti, Ivano G.
    Gadaleta, Gennaro
    Ciccarelli, Leonardina
    Piccinni, Mario N.
    D'Angelo, Angela
    Cicero, Arrigo F. G.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (06): : 887 - 895
  • [48] Safety and Efficacy of Sitagliptin Added to the Combination of Sulfonylurea and Metformin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
    Round, Elizabeth
    Shentu, Yue
    Golm, Gregory T.
    O'Neill, Edward A.
    Gantz, Ira
    Engel, Samuel S.
    Kaufman, Keith D.
    Goldstein, Barry J.
    [J]. DIABETES, 2013, 62 : A299 - A299
  • [49] Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus
    Qiu, Rong
    Capuano, George
    Meininger, Gary
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2014, 1 (02): : 54 - 60
  • [50] Comparative efficacy and safety of antihyperglycemic drug classes for patients with type 2 diabetes following failure with metformin monotherapy: A systematic review and network meta-analysis of randomized controlled trials
    Zheng, Hui
    Sigal, Ronald J.
    Coyle, Doug
    Bai, Zemin
    Johnston, Amy
    Elliott, Jesse
    Hsieh, Shuching
    Kelly, Shannon E.
    Chen, Li
    Skidmore, Becky
    Toupin-April, Karine
    Wells, George A.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (04)
12345